Low‐dose valganciclovir prophylaxis for cytomegalovirus in intermediate‐risk (R+) renal transplant recipients: Single‐center experience

Publisher： John Wiley & Sons Inc

E-ISSN： 1399-3062|19|6|tid.12780-tid.12780

ISSN： 1398-2273

Source： TRANSPLANT INFECTIOUS DISEASE (ELECTRONIC), Vol.19, Iss.6, 2017-12, pp. : n/a-n/a

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cytomegalovirus infection in high‐risk kidney transplant recipients receiving thymoglobulin induction—a single‐center experience

By  

CLINICAL TRANSPLANTATION (ELECTRONIC), Vol. 30, Iss. 9, 2016-09 ,pp. : 1159-1164

John Wiley & Sons Inc

Access to resources Recommend Favorite

Traditional and Nontraditional Cardiovascular Risk Factors and Estimated Risk for Coronary Artery Disease in Renal Transplant Recipients: A Single-Center Experience

By  

Nephron Clin Pract, Vol. 119, Iss. 3, 2011-08 ,pp. : c227-c235

Karger

Access to resources Recommend Favorite

Increased risk of breakthrough infection among cytomegalovirus donor‐positive/recipient‐negative kidney transplant recipients receiving lower‐dose valganciclovir prophylaxis

By  

TRANSPLANT INFECTIOUS DISEASE (ELECTRONIC), Vol. 17, Iss. 2, 2015-04 ,pp. : 163-173

John Wiley & Sons Inc

Access to resources Recommend Favorite

Low-Dose Valganciclovir as Preemptive Therapy for Cytomegalovirus Infection Occurring in Allogeneic Stem Cell Transplant Recipients

By  

Acta Haematologica, Vol. 123, Iss. 4, 2010-04 ,pp. : 230-234

Karger

Access to resources Recommend Favorite

Herpes zoster in kidney transplant recipients: protective effect of anti‐cytomegalovirus prophylaxis and natural killer cell count. A single‐center cohort study

By  

TRANSPLANT INTERNATIONAL (ELECTRONIC), Vol. 31, Iss. 2, 2018-02 ,pp. : 187-197

John Wiley & Sons Inc

Access to resources Recommend Favorite